IMPINJ INC (PI)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $1.6M
- Sep 21 · Unusual
- Form 4 sales
- 382
- On record
- Form 144 notices
- 91
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJun 1 2026
Sold 55,667 shares at $149.94 ($8.3M)
Sylebra Capital LLC, Director
No 10b5-1 planSold 5.4% of holdings ($153M position)966,504 shares left1.5x usual sizeFiling
- 2 Form 4 saleNo planJun 3 +2 days
Sold 45,037 shares at $141.87 ($6.4M)
Sylebra Capital LLC, Director
No 10b5-1 planSold 4.7% of holdings ($137M position)921,467 shares left1x usual sizeFiling
- 3 Form 4 saleNo planJun 4 +1 day
Sold 33,412 shares at $136.84 ($4.6M)
Sylebra Capital LLC, Director
No 10b5-1 planSold 3.6% of holdings ($126M position)888,055 shares left0.7x usual sizeFiling
- 4 Form 4 saleNo planJun 5 +1 day
Sold 47,479 shares at $124.06 ($5.9M)
Sylebra Capital LLC, Director
No 10b5-1 planSold 5.3% of holdings ($110M position)840,576 shares left1.2x usual sizeFiling
- 5 Form 4 saleNo planJun 9 +4 days
Sold 57,633 shares at $128.61 ($7.4M)
Sylebra Capital LLC, Director
No 10b5-1 planSold 6.9% of holdings ($108M position)782,943 shares left1.3x usual sizeFiling
- 6 Form 4 saleRoutineAug 10 +62 days
Sold 1,429 shares at $185.00 ($264k)
Baker Cary, CHIEF FINANCIAL OFFICER
10b5-1 planSold 1.6% of holdings ($16.6M position)88,226 shares left2.9x usual sizeFiling
- 7 Form 4 saleNo planSep 15 +36 days
Sold 800 shares at $173.26 ($139k)
Washington Miron, Director
No 10b5-1 planSold 15.5% of holdings ($893k position)4,354 shares leftFiling
- 8 Form 4 saleUnusualSep 21 +6 days
Sold 8,892 shares at $185.00 ($1.6M)
Baker Cary, CHIEF FINANCIAL OFFICER
10b5-1 planSold 10% of holdings ($16.5M position)80,388 shares left17.8x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 473)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 8,892 | $1.6M | 10.0% | Unusual | SEC |
| Sep 15, 2026 | Washington Miron | Director | Form 4 sale | 800 | $139k | 15.5% | No plan | SEC |
| Aug 10, 2026 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,429 | $264k | 1.6% | Routine | SEC |
| Jun 9, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 57,633 | $7.4M | 6.9% | No plan | SEC |
| Jun 5, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 47,479 | $5.9M | 5.3% | No plan | SEC |
| Jun 4, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 33,412 | $4.6M | 3.6% | No plan | SEC |
| Jun 3, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 45,037 | $6.4M | 4.7% | No plan | SEC |
| Jun 1, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 55,667 | $8.3M | 5.4% | No plan | SEC |
| May 8, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 25,896 | $4M | 2.4% | No plan | SEC |
| May 7, 2026 | Sylebra Capital LLC | Director | Form 4 sale | 36,171 | $5.5M | 3.1% | No plan | SEC |
| Dec 15, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 280,547 | $42.2M | 19.9% | Unusual | SEC |
| Dec 10, 2025 | Gibson Daniel Patrick | Director | Form 4 sale | 87,138 | $13.6M | 5.8% | No plan | SEC |
| Dec 5, 2025 | Gibson Daniel Patrick | Director | Form 4 sale | 45,761 | $7.7M | 3.0% | No plan | SEC |
| Dec 2, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 72,932 | $12.2M | 4.5% | No plan | SEC |
| Nov 28, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 56,853 | $9.8M | 3.4% | No plan | SEC |
| Nov 25, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 78,062 | $12.8M | 4.5% | Unusual | SEC |
| Nov 21, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 11,127 | $1.7M | 0.6% | No plan | SEC |
| Nov 12, 2025 | Gibson Daniel Patrick | Director | Form 4 sale | 3,772 | $590k | 0.2% | No plan | SEC |
| Nov 11, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 30,000 | $4.7M | 1.7% | No plan | SEC |
| Nov 7, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 6,246 | $1M | 0.3% | No plan | SEC |
| Nov 7, 2025 | Washington Miron | Director | Form 4 sale | 342 | $54k | 14.4% | No plan | SEC |
| Nov 6, 2025 | Gibson Daniel Patrick | Director | Form 4 sale | 23,157 | $4M | 1.3% | No plan | SEC |
| Nov 3, 2025 | Gibson Daniel Patrick | Director | Form 4 sale | 1,513 | $306k | 0.1% | No plan | SEC |
| Sep 16, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 9,096 | $1.7M | 3.0% | Routine | SEC |
| Sep 10, 2025 | Sylebra Capital LLC | Other | Form 4 sale | 300,000 | $58.9M | 14.1% | No plan | SEC |
| Sep 9, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.9M | 2.9% | Routine | SEC |
| Sep 3, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.9M | 2.8% | Routine | SEC |
| Aug 29, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.9M | 2.7% | Unusual | SEC |
| Feb 21, 2025 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 565 | $56k | 6.7% | No plan | SEC |
| Feb 21, 2025 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 3,739 | $369k | 5.0% | Unusual | SEC |
| Feb 21, 2025 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,553 | $153k | 2.0% | Unusual | SEC |
| Feb 21, 2025 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 2,666 | $263k | 3.6% | Unusual | SEC |
| Feb 21, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 8,334 | $823k | 2.3% | Unusual | SEC |
| Jan 13, 2025 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 378 | $53k | 0.6% | No plan | SEC |
| Jan 13, 2025 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 290 | $41k | 0.4% | No plan | SEC |
| Jan 13, 2025 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 841 | $119k | 0.3% | No plan | SEC |
| Jan 13, 2025 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 338 | $48k | 0.5% | No plan | SEC |
| Dec 24, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 210 | $31k | 2.9% | No plan | SEC |
| Dec 24, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 826 | $121k | 1.3% | No plan | SEC |
| Dec 24, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 580 | $85k | 0.9% | No plan | SEC |
| Dec 24, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 1,504 | $220k | 0.5% | No plan | SEC |
| Dec 24, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 499 | $73k | 0.7% | No plan | SEC |
| Nov 21, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 697 | $130k | 9.3% | No plan | SEC |
| Nov 21, 2024 | Phelan Cathal G | Officer, Director | Form 144 notice | 697 | $130k | Notice | SEC | |
| Nov 14, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 15,000 | $2.8M | 18.7% | Unusual | SEC |
| Nov 13, 2024 | Sylebra Capital LLC | Other | Form 4 sale | 14,476 | $2.9M | 0.7% | No plan | SEC |
| Nov 11, 2024 | Gibson Daniel Patrick | Director | Form 4 sale | 328,616 | $66.6M | 13.3% | No plan | SEC |
| Nov 8, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 11,549 | $2.3M | 65.4% | Unusual | SEC |
| Nov 7, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 25,180 | $5.1M | 7.1% | Unusual | SEC |
| Nov 7, 2024 | Gibson Daniel Patrick | Director | Form 4 sale | 431,153 | $85.9M | 14.8% | No plan | SEC |
| Nov 4, 2024 | Gibson Daniel Patrick | Director | Form 4 sale | 118,043 | $23M | 3.9% | No plan | SEC |
| Oct 30, 2024 | Gibson Daniel Patrick | Director | Form 4 sale | 175,804 | $35.3M | 5.5% | No plan | SEC |
| Oct 30, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 35,000 | $7M | 10.6% | Unusual | SEC |
| Oct 28, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 10,000 | $2M | 14.3% | Unusual | SEC |
| Oct 28, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 15,000 | $3.1M | 17.4% | Unusual | SEC |
| Oct 14, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 427 | $102k | 0.7% | No plan | SEC |
| Oct 14, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 488 | $116k | 0.7% | No plan | SEC |
| Oct 14, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 1,219 | $290k | 0.4% | No plan | SEC |
| Oct 14, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 366 | $87k | 0.5% | No plan | SEC |
| Sep 24, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 209 | $44k | 1.2% | No plan | SEC |
| Sep 24, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 822 | $172k | 1.4% | No plan | SEC |
| Sep 24, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 577 | $121k | 0.9% | No plan | SEC |
| Sep 24, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 1,498 | $313k | 0.5% | No plan | SEC |
| Sep 24, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 496 | $104k | 0.7% | No plan | SEC |
| Sep 13, 2024 | Padval Umesh | Director | Form 4 sale | 3,529 | $665k | 67.1% | Unusual | SEC |
| Aug 21, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 677 | $110k | 3.8% | No plan | SEC |
| Aug 1, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 30,000 | $4.6M | 32.0% | Unusual | SEC |
| Jul 15, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 416 | $73k | 0.7% | No plan | SEC |
| Jul 15, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 475 | $83k | 0.7% | No plan | SEC |
| Jul 15, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 356 | $62k | 0.5% | No plan | SEC |
| Jul 15, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 1,187 | $208k | 0.4% | No plan | SEC |
| Jul 8, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 5,000 | $812k | 1.7% | Unusual | SEC |
| Jul 2, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.5M | 3.3% | Unusual | SEC |
| Jun 25, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 11,519 | $1.7M | 3.8% | Unusual | SEC |
| Jun 24, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 212 | $31k | 1.3% | No plan | SEC |
| Jun 24, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 833 | $123k | 1.4% | No plan | SEC |
| Jun 24, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 584 | $86k | 0.9% | No plan | SEC |
| Jun 24, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 503 | $74k | 0.7% | No plan | SEC |
| Jun 18, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,616 | $1.6M | 3.6% | Unusual | SEC |
| Jun 17, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 495 | $74k | 0.9% | No plan | SEC |
| Jun 17, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 308 | $46k | 0.4% | No plan | SEC |
| Jun 17, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 739 | $111k | 1.2% | No plan | SEC |
| Jun 11, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.5M | 3.4% | Unusual | SEC |
| Jun 10, 2024 | Washington Miron | Director | Form 4 sale | 1,500 | $222k | 72.4% | Unusual | SEC |
| Jun 6, 2024 | Gibson Daniel Patrick | Director | Form 4 sale | 1M | $153M | 23.8% | Unusual | SEC |
| Jun 4, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 15,000 | $2.5M | 5.0% | Unusual | SEC |
| May 21, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 708 | $118k | 4.1% | No plan | SEC |
| May 2, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 10,000 | $1.6M | 12.8% | Unusual | SEC |
| May 1, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 5,000 | $772k | 8.3% | Unusual | SEC |
| Apr 26, 2024 | Padval Umesh | Director | Form 4 sale | 3,475 | $526k | 49.6% | Unusual | SEC |
| Apr 26, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 10,000 | $1.5M | 38.8% | Unusual | SEC |
| Apr 26, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 8,000 | $1.2M | 11.6% | Unusual | SEC |
| Apr 26, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 26,661 | $3.9M | 8.5% | Unusual | SEC |
| Apr 15, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 435 | $52k | 0.8% | No plan | SEC |
| Apr 15, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 498 | $59k | 0.8% | No plan | SEC |
| Apr 15, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 1,244 | $148k | 0.4% | No plan | SEC |
| Apr 15, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 374 | $44k | 0.5% | No plan | SEC |
| Mar 25, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 841 | $107k | 3.2% | No plan | SEC |
| Mar 25, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 1,456 | $185k | 2.6% | No plan | SEC |
| Mar 25, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 1,208 | $153k | 2.0% | No plan | SEC |
| Mar 25, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,062 | $136k | 1.6% | No plan | SEC |
| Mar 25, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,953 | $376k | 1.0% | No plan | SEC |
| Mar 19, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 3,000 | $358k | 4.9% | Unusual | SEC |
| Mar 18, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 489 | $61k | 0.9% | No plan | SEC |
| Mar 18, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 306 | $38k | 0.5% | No plan | SEC |
| Mar 18, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 612 | $76k | 0.2% | No plan | SEC |
| Mar 18, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 9,732 | $1.2M | 14.3% | Unusual | SEC |
| Feb 27, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 5,000 | $525k | 1.8% | Unusual | SEC |
| Feb 26, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 6,284 | $639k | 8.8% | Unusual | SEC |
| Feb 26, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 21,060 | $2.1M | 7.0% | Unusual | SEC |
| Feb 23, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 7,217 | $730k | 12.2% | Unusual | SEC |
| Feb 23, 2024 | Dossett Jeffrey | CHIEF REVENUE OFFICER | Form 4 sale | 4,858 | $491k | 7.8% | Unusual | SEC |
| Feb 21, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 2,556 | $253k | 9.3% | No plan | SEC |
| Feb 16, 2024 | Diorio Chris Ph.D. | CHIEF EXECUTIVE OFFICER | Form 4 sale | 10,000 | $1.1M | 3.8% | Unusual | SEC |
| Feb 16, 2024 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 5,000 | $527k | Notice | SEC | |
| Feb 15, 2024 | Phelan Cathal G | CHIEF INNOVATION OFFICER | Form 4 sale | 10,000 | $1.1M | 31.5% | Unusual | SEC |
| Feb 15, 2024 | Phelan Cathal G | Officer, Director | Form 144 notice | 10,000 | $1.1M | Notice | SEC | |
| Feb 15, 2024 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 5,000 | $525k | Notice | SEC | |
| Feb 14, 2024 | Baker Cary | CHIEF FINANCIAL OFFICER | Form 4 sale | 20,000 | $2M | 26.5% | Unusual | SEC |
| Feb 14, 2024 | Baker Cary | Officer | Form 144 notice | 20,000 | $2M | Notice | SEC | |
| Feb 12, 2024 | Mecklai Hussein | CHIEF OPERATING OFFICER | Form 4 sale | 30,000 | $3.1M | 42.6% | Unusual | SEC |
| Feb 12, 2024 | Mecklai Hussein | Officer | Form 144 notice | 30,000 | $3.1M | Notice | SEC | |
| Jan 16, 2024 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 325 | $26k | 0.8% | No plan | SEC |
| Jan 16, 2024 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 855 | $69k | 0.3% | No plan | SEC |
| Jan 16, 2024 | Baker Cary | Chief Financial Officer | Form 4 sale | 278 | $23k | 0.5% | No plan | SEC |
| Jan 16, 2024 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 371 | $30k | 0.8% | No plan | SEC |
| Jan 16, 2024 | Dossett Jeffrey | Officer | Form 144 notice | 371 | $30k | Notice | SEC | |
| Jan 16, 2024 | Baker Cary | Officer | Form 144 notice | 278 | $23k | Notice | SEC | |
| Jan 16, 2024 | Mecklai Hussein | Officer | Form 144 notice | 325 | $26k | Notice | SEC | |
| Jan 16, 2024 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 855 | $69k | Notice | SEC | |
| Dec 26, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,001 | $90k | 0.4% | No plan | SEC |
| Dec 26, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 603 | $54k | 1.5% | No plan | SEC |
| Dec 26, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 302 | $27k | 0.5% | No plan | SEC |
| Dec 26, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 362 | $32k | 0.8% | No plan | SEC |
| Dec 26, 2023 | Mecklai Hussein | Officer | Form 144 notice | 603 | $54k | Notice | SEC | |
| Dec 26, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 362 | $32k | Notice | SEC | |
| Dec 26, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,001 | $90k | Notice | SEC | |
| Dec 26, 2023 | Baker Cary | Officer | Form 144 notice | 302 | $27k | Notice | SEC | |
| Dec 18, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 495 | $44k | 1.3% | No plan | SEC |
| Dec 18, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 616 | $55k | 0.2% | No plan | SEC |
| Dec 18, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 308 | $27k | 0.6% | No plan | SEC |
| Dec 18, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 739 | $66k | 1.8% | No plan | SEC |
| Dec 18, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 739 | $66k | Notice | SEC | |
| Dec 18, 2023 | Baker Cary | Officer | Form 144 notice | 308 | $27k | Notice | SEC | |
| Dec 18, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 616 | $55k | Notice | SEC | |
| Dec 18, 2023 | Mecklai Hussein | Officer | Form 144 notice | 495 | $44k | Notice | SEC | |
| Nov 27, 2023 | Baker Cary | Officer | Form 144 notice | 1,468 | $122k | Notice | SEC | |
| Nov 27, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,468 | $122k | 2.7% | No plan | SEC |
| Oct 26, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,000 | $62k | 2.4% | Routine | SEC |
| Oct 26, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 1,000 | $62k | Notice | SEC | |
| Oct 13, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 436 | $23k | 1.1% | No plan | SEC |
| Oct 13, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 498 | $26k | 1.2% | No plan | SEC |
| Oct 13, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,245 | $65k | 0.4% | No plan | SEC |
| Oct 13, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 375 | $20k | 0.7% | No plan | SEC |
| Oct 13, 2023 | Baker Cary | Officer | Form 144 notice | 375 | $20k | Notice | SEC | |
| Oct 13, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,245 | $65k | Notice | SEC | |
| Oct 13, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 498 | $26k | Notice | SEC | |
| Oct 13, 2023 | Mecklai Hussein | Officer | Form 144 notice | 436 | $23k | Notice | SEC | |
| Oct 2, 2023 | Phelan Cathal G | Chief Innovation Officer | Form 4 sale | 1,082 | $58k | 4.7% | No plan | SEC |
| Oct 2, 2023 | Phelan Cathal G | Officer, Director | Form 144 notice | 1,082 | $58k | Notice | SEC | |
| Sep 25, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 366 | $20k | 0.9% | No plan | SEC |
| Sep 25, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 305 | $17k | 0.6% | No plan | SEC |
| Sep 25, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,010 | $56k | 0.3% | No plan | SEC |
| Sep 25, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 609 | $34k | 1.6% | No plan | SEC |
| Sep 25, 2023 | Mecklai Hussein | Officer | Form 144 notice | 609 | $34k | Notice | SEC | |
| Sep 25, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 366 | $20k | Notice | SEC | |
| Sep 25, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,010 | $56k | Notice | SEC | |
| Sep 25, 2023 | Baker Cary | Officer | Form 144 notice | 305 | $17k | Notice | SEC | |
| Sep 18, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 311 | $20k | 0.6% | No plan | SEC |
| Sep 18, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 499 | $32k | 1.4% | No plan | SEC |
| Sep 18, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 746 | $47k | 1.8% | No plan | SEC |
| Sep 18, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 622 | $39k | 0.2% | No plan | SEC |
| Sep 18, 2023 | Mecklai Hussein | Officer | Form 144 notice | 499 | $32k | Notice | SEC | |
| Sep 18, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 746 | $47k | Notice | SEC | |
| Sep 18, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 622 | $39k | Notice | SEC | |
| Sep 18, 2023 | Baker Cary | Officer | Form 144 notice | 311 | $20k | Notice | SEC | |
| Sep 6, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $140k | 4.9% | Routine | SEC |
| Sep 6, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 2,000 | $140k | Notice | SEC | |
| Sep 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,000 | $68k | 2.4% | Routine | SEC |
| Sep 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 1,000 | $68k | Notice | SEC | |
| Aug 25, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,485 | $89k | 2.9% | No plan | SEC |
| Aug 25, 2023 | Baker Cary | Officer | Form 144 notice | 1,485 | $89k | Notice | SEC | |
| Aug 1, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 251 | $16k | 0.7% | No plan | SEC |
| Aug 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,628 | $106k | 3.8% | Routine | SEC |
| Aug 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 628 | $41k | Notice | SEC | |
| Aug 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 1,000 | $65k | Notice | SEC | |
| Aug 1, 2023 | Mecklai Hussein | Officer | Form 144 notice | 251 | $16k | Notice | SEC | |
| Jul 13, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 421 | $38k | 1.2% | No plan | SEC |
| Jul 13, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 482 | $43k | 1.1% | No plan | SEC |
| Jul 13, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,204 | $108k | 0.4% | No plan | SEC |
| Jul 13, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 361 | $32k | 0.8% | No plan | SEC |
| Jul 13, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 482 | $43k | Notice | SEC | |
| Jul 13, 2023 | Baker Cary | Officer | Form 144 notice | 361 | $32k | Notice | SEC | |
| Jul 13, 2023 | Mecklai Hussein | Officer | Form 144 notice | 421 | $32k | Notice | SEC | |
| Jul 13, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,204 | $108k | Notice | SEC | |
| Jul 3, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 3,500 | $314k | 7.9% | Routine | SEC |
| Jul 3, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,536 | $138k | 0.5% | No plan | SEC |
| Jul 3, 2023 | Phelan Cathal G | Chief Innovation Officer | Form 4 sale | 1,042 | $94k | 4.8% | No plan | SEC |
| Jul 3, 2023 | Phelan Cathal G | Officer, Director | Form 144 notice | 1,042 | $94k | Notice | SEC | |
| Jul 3, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,536 | $138k | Notice | SEC | |
| Jul 3, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 3,500 | $314k | Notice | SEC | |
| Jun 26, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 624 | $54k | 1.8% | No plan | SEC |
| Jun 26, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 375 | $32k | 0.8% | No plan | SEC |
| Jun 26, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,035 | $89k | 0.3% | No plan | SEC |
| Jun 26, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 312 | $27k | 0.7% | No plan | SEC |
| Jun 26, 2023 | Baker Cary | Officer | Form 144 notice | 312 | $27k | Notice | SEC | |
| Jun 26, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 1,035 | $89k | Notice | SEC | |
| Jun 26, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 375 | $32k | Notice | SEC | |
| Jun 26, 2023 | Mecklai Hussein | Officer | Form 144 notice | 624 | $54k | Notice | SEC | |
| Jun 16, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 296 | $30k | 0.6% | No plan | SEC |
| Jun 16, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 709 | $72k | 1.6% | No plan | SEC |
| Jun 16, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 476 | $48k | 1.4% | No plan | SEC |
| Jun 16, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 591 | $60k | 0.2% | No plan | SEC |
| Jun 16, 2023 | Baker Cary | Officer | Form 144 notice | 296 | $30k | Notice | SEC | |
| Jun 16, 2023 | Diorio Chris Ph.D. | Officer, Director | Form 144 notice | 591 | $60k | Notice | SEC | |
| Jun 16, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 709 | $72k | Notice | SEC | |
| Jun 16, 2023 | Mecklai Hussein | Officer | Form 144 notice | 476 | $48k | Notice | SEC | |
| Jun 9, 2023 | Phelan Cathal G | Chief Innovation Officer | Form 4 sale | 1,811 | $197k | 8.4% | No plan | SEC |
| Jun 9, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 2,000 | $220k | 4.1% | Routine | SEC |
| Jun 9, 2023 | Baker Cary | Officer | Form 144 notice | 2,000 | $220k | Notice | SEC | |
| Jun 9, 2023 | Phelan Cathal G | Officer, Director | Form 144 notice | 1,811 | $197k | Notice | SEC | |
| Jun 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 3,500 | $359k | 7.6% | Routine | SEC |
| Jun 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 3,500 | $359k | Notice | SEC | |
| May 25, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,453 | $141k | 2.9% | No plan | SEC |
| May 25, 2023 | Baker Cary | Officer | Form 144 notice | 1,453 | $141k | Notice | SEC | |
| May 1, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 257 | $22k | 0.8% | No plan | SEC |
| May 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 4,141 | $364k | 8.2% | Routine | SEC |
| May 1, 2023 | Mecklai Hussein | Officer | Form 144 notice | 257 | $22k | Notice | SEC | |
| May 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 641 | $54k | Notice | SEC | |
| Apr 13, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 433 | $58k | 1.3% | No plan | SEC |
| Apr 13, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 495 | $67k | 1.0% | No plan | SEC |
| Apr 13, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,236 | $166k | 0.4% | No plan | SEC |
| Apr 13, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 371 | $50k | 0.8% | No plan | SEC |
| Apr 13, 2023 | Mecklai Hussein | Officer | Form 144 notice | 433 | $58k | Notice | SEC | |
| Apr 13, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 1,236 | $166k | Notice | SEC | |
| Apr 13, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 495 | $67k | Notice | SEC | |
| Apr 13, 2023 | Baker Cary | Officer | Form 144 notice | 371 | $50k | Notice | SEC | |
| Apr 3, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,586 | $208k | 0.5% | No plan | SEC |
| Apr 3, 2023 | Phelan Cathal G | Chief Innovation Officer | Form 4 sale | 1,118 | $147k | 5.9% | No plan | SEC |
| Apr 3, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 3,500 | $473k | 6.8% | Routine | SEC |
| Apr 3, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 1,586 | $208k | Notice | SEC | |
| Apr 3, 2023 | Phelan Cathal G | Officer | Form 144 notice | 1,118 | $147k | Notice | SEC | |
| Mar 24, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 2,589 | $330k | 7.5% | Unusual | SEC |
| Mar 24, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,553 | $198k | 2.9% | No plan | SEC |
| Mar 24, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 4,285 | $549k | 1.5% | No plan | SEC |
| Mar 24, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,294 | $165k | 2.8% | No plan | SEC |
| Mar 24, 2023 | Mecklai Hussein | Officer | Form 144 notice | 2,589 | $330k | Notice | SEC | |
| Mar 24, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 1,553 | $198k | Notice | SEC | |
| Mar 24, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 4,285 | $549k | Notice | SEC | |
| Mar 24, 2023 | Baker Cary | Officer | Form 144 notice | 1,294 | $165k | Notice | SEC | |
| Mar 16, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 480 | $62k | 1.7% | Plan not stated | SEC |
| Mar 16, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 717 | $93k | 1.4% | Plan not stated | SEC |
| Mar 16, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 597 | $77k | 0.2% | Plan not stated | SEC |
| Mar 16, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 299 | $39k | 0.7% | Plan not stated | SEC |
| Mar 16, 2023 | Mecklai Hussein | Officer | Form 144 notice | 480 | $62k | Notice | SEC | |
| Mar 16, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 717 | $93k | Notice | SEC | |
| Mar 16, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 597 | $77k | Notice | SEC | |
| Mar 16, 2023 | Baker Cary | Officer | Form 144 notice | 299 | $39k | Notice | SEC | |
| Mar 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 3,500 | $466k | 6.8% | Plan not stated | SEC |
| Mar 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 10,500 | $1.4M | Notice | SEC | |
| Feb 28, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 6,000 | $810k | 18.0% | Unusual | SEC |
| Feb 28, 2023 | Mecklai Hussein | Officer | Form 144 notice | 6,000 | $810k | Notice | SEC | |
| Feb 27, 2023 | Baker Cary | Officer | Form 144 notice | 5,202 | $664k | Notice | SEC | |
| Feb 27, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 11,692 | $1.5M | Notice | SEC | |
| Feb 27, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 5,143 | $657k | Notice | SEC | |
| Feb 27, 2023 | Mecklai Hussein | Officer | Form 144 notice | 4,801 | $613k | Notice | SEC | |
| Feb 27, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 11,692 | $1.5M | 4.0% | Unusual | SEC |
| Feb 27, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 5,143 | $657k | 9.0% | Unusual | SEC |
| Feb 27, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 4,801 | $613k | 14.9% | Unusual | SEC |
| Feb 27, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 5,202 | $664k | 10.8% | Unusual | SEC |
| Feb 22, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 10,000 | $1.2M | 3.7% | Unusual | SEC |
| Feb 21, 2023 | Sessler Gregory | Director | Form 4 sale | 2,179 | $272k | 8.1% | Plan not stated | SEC |
| Feb 14, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 1,041 | $135k | 4.8% | Plan not stated | SEC |
| Feb 14, 2023 | Mecklai Hussein | Officer | Form 144 notice | 1,041 | $135k | Notice | SEC | |
| Feb 14, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 15,000 | $1.9M | 5.2% | Unusual | SEC |
| Feb 10, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 4,147 | $512k | 16.9% | Unusual | SEC |
| Feb 10, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 3,500 | $428k | 7.4% | Plan not stated | SEC |
| Feb 10, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 5,000 | $603k | 12.6% | Unusual | SEC |
| Feb 10, 2023 | Mecklai Hussein | Officer | Form 144 notice | 4,147 | $512k | Notice | SEC | |
| Feb 10, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 3,500 | $428k | Notice | SEC | |
| Feb 10, 2023 | Baker Cary | Officer | Form 144 notice | 5,000 | $603k | Notice | SEC | |
| Feb 1, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 598 | $80k | Notice | SEC | |
| Feb 1, 2023 | Mecklai Hussein | Officer | Form 144 notice | 250 | $33k | Notice | SEC | |
| Feb 1, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 250 | $33k | 1.1% | Plan not stated | SEC |
| Feb 1, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 598 | $80k | 1.3% | Plan not stated | SEC |
| Jan 13, 2023 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 515 | $62k | 2.3% | Plan not stated | SEC |
| Jan 13, 2023 | Baker Cary | Chief Financial Officer | Form 4 sale | 404 | $49k | 1.1% | Plan not stated | SEC |
| Jan 13, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 563 | $68k | 1.2% | Plan not stated | SEC |
| Jan 13, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,226 | $148k | 0.4% | Plan not stated | SEC |
| Jan 13, 2023 | Mecklai Hussein | Officer | Form 144 notice | 515 | $62k | Notice | SEC | |
| Jan 13, 2023 | Dossett Jeffrey | Officer | Form 144 notice | 563 | $68k | Notice | SEC | |
| Jan 13, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 1,226 | $148k | Notice | SEC | |
| Jan 13, 2023 | Baker Cary | Officer | Form 144 notice | 404 | $49k | Notice | SEC | |
| Jan 4, 2023 | Diorio Chris Ph.D. | Officer | Form 144 notice | 1,612 | $177k | Notice | SEC | |
| Jan 4, 2023 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,612 | $177k | 0.6% | Plan not stated | SEC |
| Jan 3, 2023 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $222k | 4.2% | Plan not stated | SEC |
| Dec 16, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 491 | $54k | 2.2% | Plan not stated | SEC |
| Dec 16, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 306 | $34k | 0.8% | Plan not stated | SEC |
| Dec 16, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 734 | $81k | 1.7% | Plan not stated | SEC |
| Dec 16, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 612 | $67k | 0.2% | Plan not stated | SEC |
| Dec 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $255k | 4.6% | Plan not stated | SEC |
| Nov 29, 2022 | Gibson Daniel Patrick | Director | Form 4 sale | 10,684 | $1.3M | 0.4% | Plan not stated | SEC |
| Nov 28, 2022 | Gibson Daniel Patrick | Director | Form 4 sale | 239,176 | $29.2M | 8.0% | Plan not stated | SEC |
| Nov 25, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,457 | $180k | 3.9% | Plan not stated | SEC |
| Nov 22, 2022 | Gibson Daniel Patrick | Director | Form 4 sale | 127,689 | $14.7M | 4.1% | Plan not stated | SEC |
| Nov 17, 2022 | Gibson Daniel Patrick | Director | Form 4 sale | 157,489 | $17.4M | 4.7% | Plan not stated | SEC |
| Nov 15, 2022 | Sylebra Capital Ltd | 10% owner | Form 4 sale | 64,911 | $7.6M | 1.9% | Plan not stated | SEC |
| Nov 1, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 252 | $28k | 1.2% | Plan not stated | SEC |
| Nov 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,629 | $301k | 5.7% | Plan not stated | SEC |
| Nov 1, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 5,000 | $567k | 1.7% | Plan not stated | SEC |
| Oct 31, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 15,000 | $1.7M | 4.9% | Unusual | SEC |
| Oct 28, 2022 | Phelan Cathal G | Director | Form 4 sale | 10,000 | $1.1M | 39.9% | Unusual | SEC |
| Oct 28, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 21,000 | $2.3M | 50.7% | Unusual | SEC |
| Oct 28, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 4,875 | $539k | 12.8% | Unusual | SEC |
| Oct 13, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 427 | $34k | 1.3% | Plan not stated | SEC |
| Oct 13, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 488 | $39k | 1.1% | Plan not stated | SEC |
| Oct 13, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,218 | $96k | 0.4% | Plan not stated | SEC |
| Oct 13, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 366 | $29k | 1.0% | Plan not stated | SEC |
| Oct 3, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $160k | 4.3% | Plan not stated | SEC |
| Oct 3, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,452 | $123k | 0.5% | Plan not stated | SEC |
| Sep 16, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 519 | $46k | 1.6% | Plan not stated | SEC |
| Sep 16, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 777 | $68k | 1.7% | Plan not stated | SEC |
| Sep 16, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 647 | $57k | 0.2% | Plan not stated | SEC |
| Sep 16, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 324 | $28k | 0.9% | Plan not stated | SEC |
| Sep 9, 2022 | Sessler Gregory | Director | Form 4 sale | 670 | $62k | 2.4% | Plan not stated | SEC |
| Sep 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $176k | 4.3% | Plan not stated | SEC |
| Aug 25, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,452 | $139k | 4.1% | Plan not stated | SEC |
| Aug 23, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 10,000 | $923k | 3.2% | Unusual | SEC |
| Aug 17, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 10,000 | $958k | 3.1% | Unusual | SEC |
| Aug 3, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 9,000 | $801k | 22.5% | Unusual | SEC |
| Aug 3, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 3,000 | $270k | 8.6% | Plan not stated | SEC |
| Aug 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 6,612 | $546k | 12.3% | Unusual | SEC |
| Aug 1, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 18,246 | $1.5M | 37.0% | Unusual | SEC |
| Jul 29, 2022 | Phelan Cathal G | Director | Form 4 sale | 20,000 | $1.6M | 57.0% | Unusual | SEC |
| Jul 29, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 11,875 | $981k | 27.2% | Unusual | SEC |
| Jul 13, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 435 | $28k | 1.1% | Plan not stated | SEC |
| Jul 13, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 497 | $32k | 0.9% | Plan not stated | SEC |
| Jul 13, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,242 | $80k | 0.4% | Plan not stated | SEC |
| Jul 13, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 373 | $24k | 1.0% | Plan not stated | SEC |
| Jul 5, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,500 | $90k | 2.8% | Plan not stated | SEC |
| Jul 5, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,473 | $84k | 0.5% | Plan not stated | SEC |
| Jul 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 500 | $29k | 0.9% | Plan not stated | SEC |
| Jun 16, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 519 | $25k | 1.3% | Plan not stated | SEC |
| Jun 16, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 323 | $15k | 0.9% | Plan not stated | SEC |
| Jun 16, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 775 | $37k | 1.4% | Plan not stated | SEC |
| Jun 16, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 646 | $31k | 0.2% | Plan not stated | SEC |
| Jun 2, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 500 | $25k | 0.9% | Plan not stated | SEC |
| May 25, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,458 | $63k | 3.8% | Plan not stated | SEC |
| May 2, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 237 | $12k | 0.6% | Plan not stated | SEC |
| May 2, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,091 | $55k | 2.0% | Plan not stated | SEC |
| Apr 13, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,637 | $157k | 4.8% | Plan not stated | SEC |
| Apr 13, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 4,824 | $253k | 1.5% | Plan not stated | SEC |
| Apr 13, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 1,688 | $88k | 4.3% | Plan not stated | SEC |
| Apr 13, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,448 | $76k | 4.0% | Plan not stated | SEC |
| Apr 4, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,495 | $96k | 0.5% | Plan not stated | SEC |
| Apr 1, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,000 | $64k | 2.0% | Plan not stated | SEC |
| Mar 16, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 473 | $29k | 1.3% | Plan not stated | SEC |
| Mar 16, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 706 | $43k | 1.4% | Plan not stated | SEC |
| Mar 16, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 588 | $36k | 0.2% | Plan not stated | SEC |
| Mar 16, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 294 | $18k | 0.9% | Plan not stated | SEC |
| Mar 3, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,000 | $138k | 4.0% | Plan not stated | SEC |
| Feb 25, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,473 | $99k | 4.5% | Plan not stated | SEC |
| Feb 16, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 5,000 | $350k | 1.6% | Plan not stated | SEC |
| Feb 14, 2022 | Baker Cary | Chief Financial Officer | Form 4 sale | 5,486 | $373k | 15.8% | Plan not stated | SEC |
| Feb 14, 2022 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 9,602 | $656k | 16.1% | Unusual | SEC |
| Feb 14, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 9,626 | $656k | 3.2% | Plan not stated | SEC |
| Feb 14, 2022 | Mecklai Hussein | Chief Operating Officer | Form 4 sale | 6,513 | $443k | 15.9% | Plan not stated | SEC |
| Feb 11, 2022 | Phelan Cathal G | Director | Form 4 sale | 20,000 | $1.4M | 60.1% | Unusual | SEC |
| Jan 4, 2022 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,648 | $144k | 0.6% | Plan not stated | SEC |
| Dec 16, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 805 | $65k | 1.9% | Plan not stated | SEC |
| Dec 16, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 670 | $54k | 0.2% | Plan not stated | SEC |
| Dec 16, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 337 | $27k | 1.6% | Plan not stated | SEC |
| Dec 8, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 2,500 | $207k | 11.0% | Plan not stated | SEC |
| Dec 8, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 5,000 | $414k | 11.1% | Unusual | SEC |
| Nov 26, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,515 | $114k | 6.2% | Plan not stated | SEC |
| Nov 16, 2021 | Sylebra Capital Ltd | Director, 10% owner | Form 4 sale | 1M | $78.3M | 22.7% | Plan not stated | SEC |
| Nov 4, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 30,000 | $2.4M | 9.8% | Unusual | SEC |
| Nov 4, 2021 | Van Oppen Peter H | Director | Form 4 sale | 10,000 | $790k | 30.5% | Unusual | SEC |
| Nov 4, 2021 | Sessler Gregory | Director | Form 4 sale | 4,360 | $352k | 14.5% | Plan not stated | SEC |
| Nov 3, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 9,000 | $720k | 30.4% | Unusual | SEC |
| Nov 3, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 10,000 | $759k | 3.4% | Plan not stated | SEC |
| Nov 1, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 592 | $43k | 1.3% | Plan not stated | SEC |
| Oct 28, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 2,500 | $152k | 10.8% | Plan not stated | SEC |
| Oct 4, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,603 | $86k | 0.5% | Plan not stated | SEC |
| Sep 16, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 722 | $40k | 1.8% | Plan not stated | SEC |
| Sep 16, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 601 | $33k | 0.2% | Plan not stated | SEC |
| Sep 16, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 301 | $17k | 1.3% | Plan not stated | SEC |
| Aug 30, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 5,000 | $300k | 18.1% | Unusual | SEC |
| Aug 25, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,397 | $79k | 4.8% | Plan not stated | SEC |
| Aug 2, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,106 | $94k | 5.3% | Plan not stated | SEC |
| Jul 2, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,546 | $77k | 0.5% | Plan not stated | SEC |
| Jun 16, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 2,492 | $123k | 0.8% | Plan not stated | SEC |
| Jun 16, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,990 | $148k | 7.5% | Plan not stated | SEC |
| Jun 16, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,247 | $62k | 4.7% | Plan not stated | SEC |
| Jun 2, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,500 | $79k | 4.4% | Plan not stated | SEC |
| May 25, 2021 | Baker Cary | Chief Financial Officer | Form 4 sale | 1,503 | $75k | 6.0% | Plan not stated | SEC |
| May 5, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,500 | $76k | 4.4% | Plan not stated | SEC |
| May 3, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 2,085 | $98k | 6.0% | Plan not stated | SEC |
| Apr 5, 2021 | Diorio Chris Ph.D. | Chief Executive Officer | Form 4 sale | 1,543 | $91k | 0.5% | Plan not stated | SEC |
| Mar 3, 2021 | Dossett Jeffrey | Chief Revenue Officer | Form 4 sale | 1,500 | $94k | 4.5% | Plan not stated | SEC |